Oct 31, 2019
Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults
Oct 31, 2019
2019 Research Grant Recipients Announced by the VHL Alliance
Oct 23, 2019
Allievex Completes Series A Financing Led by Pappas Capital and Novo Holdings
Oct 01, 2019
Neurocrine Biosciences to Present Data Analyses Demonstrating the Long-Term Effectiveness of INGREZZA® (valbenazine) in Patients with Tardive Dyskinesia at the 2019 Annual Psych Congress
Sep 26, 2019
The Alex Manfull Memorial Fund: Supporting Research, Education and Treatment of PANDAS in Adolescents and Young Adults
Sep 05, 2019
National Survey Reveals Glaucoma Has Significant Impact on Patients' and Caregivers' Daily Lives and Well-Being
Sep 03, 2019
JPMA Kicks Off 2019 Baby Safety Month with Safety Tips for Parents and Caregivers.
Jul 23, 2019
New Studies Suggest Prenatal Marijuana Exposure May be Capable of Inducing FASD-Like Impairment
Jul 22, 2019
SVS: Is Thoracic Outlet Syndrome More Common Or Just Better Understood?
Jul 03, 2019
Mucopolysaccharidosis (MPS) Treatment Market: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029
Jun 27, 2019
Fragile X Syndrome Market Spotlight, 2019 - There Have Been 5 Licensing & Asset Acquisition Deals Involving FXS Drugs During 2014-2019
Jun 03, 2019
Kyowa Kirin Presents Post-Hoc Analysis of Pivotal Trial for Poteligeo® (mogamulizumab-kpkc)
May 23, 2019
Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium
May 20, 2019
Neurocrine Biosciences Presents New Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia, Demonstrating the Effect of Involuntary Movements on Patient Quality of Life
May 17, 2019
Therachon to Present Data from Ongoing Phase II Study of Apraglutide for Short Bowel Syndrome (SBS) at Digestive Disease Week
May 06, 2019
Neurocrine Biosciences Honors Mental Health Month and Raises Awareness of Tardive Dyskinesia and its Impact on Patients
Apr 02, 2019
Dermelix Biotherapeutics Announces Partnership with EspeRare for Pivotal-stage Antenatal Protein Replacement Therapy for XLHED
Mar 21, 2019
Allied Pain & Spine Institute Now Offering Virtual Reality Services For Chronic Pain Patients
Jan 08, 2019
Embrace by Empatica Receives First of Its Kind FDA Clearance in Epilepsy for Children
Dec 28, 2018
Aerodiagnostics Welcomes Dr. Kathleen O'Neil-Smith as Medical Director